ProShare Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $19.7K | Sell |
|
|||||
|
2024
Q4 | $48.8K | Sell |
|
|||||
|
2024
Q3 | $110K | Buy |
|
|||||
|
2024
Q2 | $49.8K | Sell |
|
|||||
|
2024
Q1 | $243K | Buy |
|
|||||
|
2023
Q4 | $215K | Buy |
|
|||||
|
2023
Q3 | $244K | Buy |
|
|||||
|
2023
Q2 | $289K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $217K | Buy |
|
|||||
|
2022
Q3 | $217K | Buy |
|
|||||
|
2022
Q2 | $245K | Sell |
|
|||||
|
2022
Q1 | $534K | Sell |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|
|||||
|
2021
Q3 | $947K | Sell |
|
|||||
|
2021
Q2 | $854K | Buy |
|
|||||
|
2021
Q1 | $577K | Buy |
|
|||||
|
2020
Q4 | $656K | Buy |
|